|
|
|
Volumn 2, Issue 4, 2001, Pages 197-205
|
|
Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DEFIBRILLATOR;
FEMALE;
HEART VENTRICLE FIBRILLATION;
HEART VENTRICLE TACHYCARDIA;
HUMAN;
MALE;
METHODOLOGY;
MORTALITY;
PRIMARY PREVENTION;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SENSITIVITY AND SPECIFICITY;
SUDDEN DEATH;
SURVIVAL;
TREATMENT OUTCOME;
UTILIZATION REVIEW;
ANTI-ARRHYTHMIA AGENTS;
DEATH, SUDDEN, CARDIAC;
DEFIBRILLATORS, IMPLANTABLE;
FEMALE;
HUMANS;
MALE;
PRIMARY PREVENTION;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
SENSITIVITY AND SPECIFICITY;
SURVIVAL ANALYSIS;
TACHYCARDIA, VENTRICULAR;
TREATMENT OUTCOME;
VENTRICULAR FIBRILLATION;
|
|
EID: 0035453444
PISSN: 15306550
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (39)
|
